Rifampicin Capsule 150 mg

Here’s the detailed profile for Rifampicin Capsule 150 mg πŸ‘‡


πŸ’Š Rifampicin Capsule 150 mg


πŸ“˜ Description:

  • Rifampicin is a semisynthetic rifamycin antibiotic.
  • It works by inhibiting DNA-dependent RNA polymerase in bacteria, thereby blocking RNA synthesis.
  • It is a bactericidal drug with a broad spectrum of activity, particularly against mycobacteria.
  • Essential component of multidrug therapy (MDT) for leprosy and first-line regimen for tuberculosis (TB).

πŸ“„ Prescription / Indications:

  • Tuberculosis (TB) – cornerstone drug in first-line anti-TB therapy (always used in combination)
  • Leprosy (Hansen’s disease) – as part of WHO MDT
  • Other mycobacterial infections – atypical mycobacteria
  • Prophylaxis of meningococcal meningitis (short-course preventive therapy)
  • Staphylococcal infections (in combination)

🌿 Nature / Drug Class:

  • Rifamycin antibiotic
  • Potent antimycobacterial
  • Bactericidal

βœ… Advantages:

  • Highly effective bactericidal activity against Mycobacterium tuberculosis and M. leprae
  • Essential in TB cure regimens
  • Single-dose supervised therapy in MDT for leprosy improves compliance
  • Effective prophylaxis for meningococcal disease

⚠️ Precautions:

Contraindications:

  • Known hypersensitivity to rifampicin or other rifamycins
  • Severe liver impairment

Use with caution in:

  • Patients with hepatic disease, alcoholism, or concurrent hepatotoxic drugs
  • Patients on multiple medications – strong inducer of liver enzymes (CYP450) β†’ reduces effectiveness of many drugs (e.g., oral contraceptives, anticoagulants, antiretrovirals, azoles, etc.)

Adverse effects:

  • Common: GI upset (nausea, vomiting, diarrhea), headache, rash
  • Hepatotoxicity – elevated liver enzymes, hepatitis
  • Discoloration: causes orange-red coloration of urine, sweat, tears, sputum, contact lenses
  • Flu-like syndrome with intermittent dosing
  • Rare: thrombocytopenia, hemolysis, renal impairment

πŸ’Š Dosage (Adults):

  • Tuberculosis: 10 mg/kg (usually 450–600 mg daily depending on weight)
  • Leprosy (MDT): 600 mg once monthly (supervised dose)
  • Meningococcal prophylaxis: 600 mg every 12 hours for 2 days

πŸ‘‰ The 150 mg capsule is often used for dose adjustments in children, low body weight adults, or when combined with other strengths to reach the required dose.


πŸ“¦ Common Packaging:

  • Capsules 150 mg (and also 300 mg)
  • Blister strips or bottles
  • Included in WHO MDT blister packs (with dapsone & clofazimine) for leprosy

❄️ Storage Conditions:

  • Store at room temperature (<25Β°C)
  • Protect from light and moisture
  • Keep away from children

Leave a Comment

Your email address will not be published. Required fields are marked *

Call Now Button